Rekha Parameswaran, MD

Patients with cancer may develop abnormal blood clots. I work closely with the medical oncologists in all specialties to ensure that patients are treated safely and appropriately for blood clots while receiving cancer chemotherapy.

Chemotherapy can often lower the blood counts such as white cells, red cells and platelets. I also specialize in the evaluation and treatment of abnormalities in the blood counts to allow patients to proceed with chemotherapy with mimimal side effects related to low counts.

I am currently the chair of the hemostasis study group of the Multinational Association of Supportive Care in Cancer. My research interests include studying the optimal treatment and duration of treatment of cancer associated thrombosis.